NORTHFIELD, IL – Net sales for the second quarter at Medtrade exhibitor Medline Inc. hit $7.7 billion, an increase of 11.6% over the same period last year. “Our second quarter results reflect strong execution of our growth strategy, and the operational resilience of our team,” said Jim Boyle, CEO of Medline. “We delivered robust top-line growth in the quarter, secured over 65% of our annual goal in total new customer signings during the first half of 2026.
“We moved swiftly to minimize disruption from the fire at our Tracy, California distribution center, demonstrating an unwavering commitment to our customers,” Boyle continued via press release. “At the same time, we are effectively managing a dynamic external environment while investing in strategic initiatives to strengthen our market position and support long-term shareholder value creation.”
IEEPA Tariff Refunds
Following the Supreme Court’s Feb 2026 ruling that IEEPA tariffs were unauthorized, Medline recognized $243 million of net IEEPA tariff refund benefits during the three and six months ended June 27, 2026, reflecting $332 million of tariff refunds as a reduction of cost of goods sold, partially offset by $89 million of accrued customer repayments associated with IEEPA tariff refunds as a reduction of net sales. These amounts were recorded entirely within the Medline Brand segment and were included in net income and Adjusted EBITDA.
